Hypothesizing that brain reward circuitry genes are genetic antecedents of pain sensitivity and critical diagnostic and pharmacogenomic treatment targets for chronic pain conditions.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Medical Hypotheses

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.mehy.2008.07.059PMID 18951726PMCID PMC4098664
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A Developmental Approach

  2011cited by this paper
• The H-Wave® device is an effective and safe non-pharmacological analgesic for chronic pain: a meta-analysis

  2008cited by this paper
• Glucose-6-phosphate dehydrogenase deficiency: a historical perspective.

  2008cited by this paper
• Exploring the genetic susceptibility of chronic widespread pain: the tender points in genetic association studies.

  2008cited by this paper
• Dopamine D2 receptor Taq A1 allele predicts treatment compliance of LG839 in a subset analysis of pilot study in the Netherlands

  2008cited by this paper
• Health economics of nutrigenomics in weight management

  2008cited by this paper
• Recent advances in the pharmacogenomics of pain and headache

  2007cited by this paper
• Gene Narcotic Attenuation Program attenuates substance use disorder, a clinical subtype of reward deficiency syndrome

  2007cited by this paper
• Two novel mutations in the BCHE gene in patients with prolonged duration of action of mivacurium or succinylcholine during anaesthesia

  2007cited by this paper
• Genetic Variants in the DRD2 Gene Moderate the Relationship Between Stressful Life Events and Depressive Symptoms in Adults: Cardiovascular Risk in Young Finns Study

  2007cited by this paper
• Genes and (Common) Pathways Underlying Drug Addiction

  2007cited by this paper
• Genetic factors in pain and its treatment

  2007cited by this paper
• The effect of dopamine D2, D5 receptor and transporter (SLC6A3) polymorphisms on the cue‐elicited heroin craving in Chinese

  2006cited by this paper
• ABCB1 and cytochrome P450 genotypes and phenotypes: Influence on methadone plasma levels and response to treatment

  2006cited by this paper
• ABCB1 genetic variability and methadone dosage requirements in opioid‐dependent individuals

  2006cited by this paper
• The D2 dopamine receptor (DRD2) gene is associated with co-morbid depression, anxiety and social dysfunction in untreated veterans with post-traumatic stress disorder

  2006cited by this paper
• Evolution of the Neuromatrix Theory of Pain. The Prithvi Raj Lecture: Presented at the Third World Congress of World Institute of Pain, Barcelona 2004

  2005cited by this paper
• Regulation of Gene Expression by Chronic Morphine and Morphine Withdrawal in the Locus Ceruleus and Ventral Tegmental Area

  2005cited by this paper
• Stress and dopamine: implications for the pathophysiology of chronic widespread pain.

  2004cited by this paper
• Association of specific haplotypes of D2 dopamine receptor gene with vulnerability to heroin dependence in 2 distinct populations.

  2004cited by this paper
• Genetic Predictors of the Clinical Response to Opioid Analgesics

  2004cited by this paper
• Stimulation of dopamine D2 receptors in the nucleus accumbens inhibits inflammatory pain.

  2003cited by this paper
• Striatal dopamine D1 and D2 receptors in burning mouth syndrome

  2003cited by this paper
• [Association study of heroin-dependence and -287 A/G polymorphism of catechol-O-methyltransferase gene].

  2002cited by this paper
• VNTR Polymorphisms of the Serotonin Transporter and Dopamine Transporter Genes in Male Opiate Addicts

  2002cited by this paper
• Does the A118G Polymorphism at the &mgr;-opioid Receptor Gene Protect against Morphine-6-Glucuronide Toxicity?

  2002cited by this paper
• Dopamine D2 receptor binding in the human brain is associated with the response to painful stimulation and pain modulatory capacity

  2002cited by this paper
• μ‐Receptor agonism with alfentanil increases striatal dopamine D2 receptor binding in man

  2002cited by this paper
• Cerebrospinal fluid biogenic amine metabolites, plasma-rich platelet serotonin and [3H]imipramine reuptake in the primary fibromyalgia syndrome.

  2001cited by this paper
• The involvement of dopamine in nociception: the role of D(1) and D(2) receptors in the dorsolateral striatum.

  2000cited by this paper
• The D(2) dopamine receptor A(1) allele and opioid dependence: association with heroin use and response to methadone treatment.

  2000cited by this paper
• Long-lasting delayed hyperalgesia after subchronic swim stress.

  2000cited by this paper
• The Reward Deficiency Syndrome: A Biogenetic Model for the Diagnosis and Treatment of Impulsive, Addictive and Compulsive Behaviors

  2000cited by this paper
• The proenkephalin gene (PENK) and opioid dependence.

  1999cited by this paper
• Involvement of dopamine D2 and 5-HT1A receptors in roxindole-induced antinociception.

  1999cited by this paper
• The tachykinin NK-1 receptor antagonist, RP-67580, infused into the ventral tegmental area prevents stress-induced analgesia in the formalin test.

  1999cited by this paper
• The role of dopamine in the nucleus accumbens in analgesia.

  1999cited by this paper
• Serotonin transporter gene polymorphism and schizophrenia: An association study

  1998cited by this paper
• Drug dependence: stress and dysregulation of brain reward pathways.

  1998cited by this paper
• The effect of imipramine on the amount of mRNA coding for rat dopamine D2 autoreceptors.

  1997cited by this paper
• Dopamine D2 receptor (DRD2) gene and susceptibility to posttraumatic stress disorder: a study and replication.

  1996cited by this paper
• Selective activation of dopamine transmission in the shell of the nucleus accumbens by stress.

  1995cited by this paper
• One or two genetic loci mediate high opiate analgesia in selectively bred mice

  1995cited by this paper
• The fibromyalgia and myofascial pain syndromes: a preliminary study of tender points and trigger points in persons with fibromyalgia, myofascial pain syndrome and no disease.

  1992cited by this paper
• Prefrontal cortical dopamine depletion enhances the responsiveness of mesolimbic dopamine neurons to stress.

  1990cited by this paper
• 6-Hydroxydopamine lesions of the ventral tegmentum abolish D-amphetamine and morphine analgesia in the formalin test but not in the tail flick test.

  1990cited by this paper
• Enkephalinase inhibition and precursor amino acid loading improves inpatient treatment of alcohol and polydrug abusers: double-blind placebo-controlled study of the nutritional adjunct SAAVE.

  1988cited by this paper
• Enkephalin release into the ventral tegmental area in response to stress: modulation of mesocorticolimbic dopamine.

  1987influential reference
• Nociceptive pathways: anatomy and physiology of nociceptive ascending pathways.

  1985cited by this paper

• Beyond Stigma-Integrating Neurobiology, Genetics, and Awareness Integration Theory in Addiction Recovery.

  2026cites this paper
• Chronic Pain and Posttraumatic Stress Among Patients in Substance Use Treatment: Protocol for NOR-APT, a Longitudinal Cohort Study

  2025cites this paper
• Exercise-driven modulation of glutamatergic signaling: mechanisms and clinical implications.

  2025cites this paper
• A Pharmacogenomics-Based In Silico Investigation of Opioid Prescribing in Post-operative Spine Pain Management and Personalized Therapy

  2024cites this paper
• Positive Clinical Outcomes for Severe Reported Pain Using Robust Non-Addictive Home Electrotherapy—A Case-Series

  2023cites this paper
• Precision Behavioral Management (PBM) and Cognitive Control as a Potential Therapeutic and Prophylactic Modality for Reward Deficiency Syndrome (RDS): Is There Enough Evidence?

  2022cites this paper
• Genetic Addiction Risk and Psychological Profiling Analyses for “Preaddiction” Severity Index

  2022cites this paper
• Corticostriatal circuits in the transition to chronic back pain: The predictive role of reward learning

  2022cites this paper
• Hypothesizing in the Face of the Opioid Crisis Coupling Genetic Addiction Risk Severity (GARS) Testing with Electrotherapeutic Nonopioid Modalities Such as H-Wave Could Attenuate Both Pain and Hedonic Addictive Behaviors

  2022cites this paper
• Neuroinflammation as a possible link between attention-deficit/hyperactivity disorder (ADHD) and pain.

  2021cites this paper
• PRBM_A_292958 2115..2134

  2021cites this paper
• A Review of DNA Risk Alleles to Determine Epigenetic Repair of mRNA Expression to Prove Therapeutic Effectiveness in Reward Deficiency Syndrome (RDS): Embracing “Precision Behavioral Management”

  2021cites this paper
• Reward Deficiency Syndrome (RDS): A Cytoarchitectural Common Neurobiological Trait of All Addictions

  2021influential citation
• High Genetic Addiction Risk Score (GARS) in Chronically Prescribed Severe Chronic Opioid Probands Attending Multi-pain Clinics: an Open Clinical Pilot Trial

  2021cites this paper
• Adolescent Drug Misuse Prevention: Challenges in School-Based Programming

  2020cites this paper
• Behavioral Economics and Addictive Disorders

  2020cites this paper
• Precision Behavioral Management (PBM): A Novel Genetically Guided Therapy to Combat Reward Deficiency Syndrome (RDS) Relevant to the Opiate Crisis

  2020cites this paper
• Sensitization of Incentive Salience and the Transition to Addiction

  2020cites this paper
• Measurement, Prevention, and Treatment of Exercise Addiction

  2020cites this paper
• Treatment of Alcohol, Tobacco, and Other Drug (ATOD) Misuse

  2020cites this paper
• Prevention and Treatment of Compulsive Buying Disorder

  2020cites this paper
• The Role of Culture in Addiction

  2020cites this paper
• Human Neurobiological Approaches to Hedonically Motivated Behaviors

  2020cites this paper
• Human Laboratory Paradigms in Addictions Research

  2020cites this paper
• Novel Psychoactive Substances: A New Challenge for Prevention and Treatment

  2020cites this paper
• The Prevention and Treatment of Gambling Disorders: Some Art, Some Science

  2020cites this paper
• Passionate Love Addiction: An Evolutionary Survival Mechanism That Can Go Terribly Wrong

  2020cites this paper
• The Physical and Social Environments as Determinants of Health: Implications for Substance and Behavioral Addictions

  2020cites this paper
• Tanning as an Addiction: The State of the Research and Implications for Intervention

  2020cites this paper
• Considering the Overlap and Nonoverlap of Compulsivity, Impulsivity, and Addiction

  2020cites this paper
• American Legal Issues in Addiction Treatment and Research

  2020cites this paper
• Neurobiological Foundations of Behavioral Addictions

  2020cites this paper
• Prevention and Treatment of Work Addiction

  2020cites this paper
• Prevention and Treatment of “Food Addiction”

  2020cites this paper
• Substance and Behavioral Addictions Assessment Instruments

  2020cites this paper
• Multiple Memory Systems, Addiction, and Health Habits: New Routes for Translational Science

  2020cites this paper
• Concepts of Addiction

  2020cites this paper
• Preface

  2020cites this paper
• Impaired Physicians

  2020cites this paper
• Levels of Analysis and Etiology

  2020cites this paper
• Hypothesizing High Negative Emotionality as a Function of Genetic Addiction Risk Severity (GARS) Testing in Alcohol Use Disorder (AUD)

  2020cites this paper
• Foreword

  2020cites this paper
• Clinical and Research Methods in the Addictions

  2020cites this paper
• Index

  2020cites this paper
• The Cambridge Handbook of Substance and Behavioral Addictions

  2020cites this paper
• Ongoing and Future Research Directions

  2020cites this paper
• Prevention and Treatment

  2020cites this paper
• Gaming Disorder and Its Treatment

  2020cites this paper
• Mindfulness-Based Interventions Applied to Addiction Treatments

  2020cites this paper
• Appetitive Needs and Addiction

  2020cites this paper
• Anhedonia in Addictive Behaviors

  2020cites this paper
• Feedback Models for Gambling Control: The Use and Efficacy of Online Responsible Gambling Tools

  2020cites this paper
• Food versus Eating Addictions

  2020cites this paper
• Philosophical Issues in the Addictions

  2020cites this paper
• Qualitative Approaches to the Study of Substance and Behavioral Addictions

  2020cites this paper
• Behavioral Economic Considerations of Novel Addictions and Nonaddictive Behavior: Research and Analytic Methods

  2020cites this paper
• Foreword: What are the Boundaries of Addictions?

  2020cites this paper
• Neurobiology of Substance Addictions

  2020cites this paper
• Prevention and Treatment of Sex Addiction

  2020cites this paper
• The Benefits of Genetic Addiction Risk Score (GARS™) Testing in Substance Use Disorder (SUD).

  2018cites this paper
• Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

  2018influential citation
• Promoting Precision Addiction Management (PAM) to Combat the Global Opioid Crisis.

  2018cites this paper
• Genetic Addiction Risk Testing Coupled with Pro-Dopamine Homeostasis, and Electro Therapy, May Overcome Aberrant Reward Seeking Behaviors: Analytic Evidence

  2018cites this paper
• Genetic addiction risk score (GARS) ™, a predictor of vulnerability to opioid dependence.

  2018cites this paper
• Neurogenetics of acute and chronic opiate/opioid abstinence: treating symptoms and the cause.

  2017cites this paper
• Reducing pain from heel lances in neonates following education on oral sucrose

  2015cites this paper
• Can Genetic Testing Provide Information to Develop Customized Nutrigenomic Solutions for Reward Deficiency Syndrome?

  2015cites this paper
• Affect dynamics : a focus on genes, stress, and an opportunity for change

  2015cites this paper
• Hypothesizing Benefits of the Incorporation of Genetic Addiction Risk Score (GARSRX™Rx™) and Dopamine Agonist Modalities (DAM) in Clinical Addiction Medicine.

  2014cites this paper
• The promise of using personalized genomic information to promote behavior change: is the debate over, or just beginning?

  2014cites this paper
• Can Genetic Testing Coupled with Enhanced Dopaminergic Activation Reduce Recidivism Rates in the Workers Compensation Legacy Cases?

  2014cites this paper
• Genetic Addiction Risk Score (GARS): Molecular Neurogenetic Evidence for Predisposition to Reward Deficiency Syndrome (RDS)

  2014cites this paper
• Depressive Disorders And Pain: A Joint Model Of Diagnosis And Treatment

  2013cites this paper
• Coupling Genetic Addiction Risk Score (GARS) with Electrotherapy: Fighting Iatrogenic Opioid Dependence

  2013cites this paper
• Withdrawal from Buprenorphine/Naloxone and Maintenance with a Natural Dopaminergic Agonist: A Cautionary Note.

  2013cites this paper
• Nociceptive stimuli responses at different levels of general anaesthesia and genetic variability

  2013cites this paper
• Sexual dysfunction is related with childhood trauma in female patients with fibromyalgia

  2013cites this paper
• Neurogenetics and nutrigenomics of reward deficiency syndrome (RDS): Stratification of addiction risk and mesolimbic nutrigenomic manipulation of hypodopaminergic function

  2013cites this paper
• Kenneth Blum 1,5,6,8,10,11,12,15*, Marlene Oscar-Berman2, Elizabeth Stuller3, David Miller4,5, John Giordano6, Siobhan Morse6, Lee McCormick7, William Downs B5, Roger L Waite5, Debmalya Barh8, Dennis Neal9, Eric R Braverman1,10, Raquel Lohmann10, Joan Borsten11, Mary Hauser12, David Han13, Yijun Liu

  2012cites this paper
• Neurological diseases and pain.

  2012cites this paper
• Neurogenetics and Nutrigenomics of Neuro-Nutrient Therapy for Reward Deficiency Syndrome (RDS): Clinical Ramifications as a Function of Molecular Neurobiological Mechanisms.

  2012cites this paper
• In Medication‐Overuse Headache, fMRI Shows Long‐Lasting Dysfunction in Midbrain Areas

  2012cites this paper
• Managing the Placebo Effect: Enhancing the Signal-to-Noise Ratio

  2011cites this paper
• Can the Chronic Administration of the Combination of Buprenorphine and Naloxone Block Dopaminergic Activity Causing Anti-reward and Relapse Potential?

  2011cites this paper
• Therapeutic Hypothermia in Stroke and Traumatic Brain Injury

  2011cites this paper
• Neuro-psychopharmacogenetics and Neurological Antecedents of Posttraumatic Stress Disorder: Unlocking the Mysteries of Resilience and Vulnerability

  2010cites this paper
• Considerations for Using Sucrose to Reduce Procedural Pain in Preterm Infants

  2010cites this paper
• Associations between polymorphisms in dopamine neurotransmitter pathway genes and pain response in healthy humans

  2009cites this paper
• The H-Wave® Device Induces NO-dependent Augmented Microcirculation and Angiogenesis, Providing Both Analgesia and Tissue Healing in Sports Injuries

  2008cites this paper
• The H-Wave® device is an effective and safe non-pharmacological analgesic for chronic pain: a meta-analysis

  2008cites this paper